Total Payments
$14,181
2024 Payments
$2,605
Companies
2
Transactions
39
Medicare Patients
697
Medicare Billing
$737,312
Payment Breakdown by Category
Consulting$11,554 (81.5%)
Other$2,450 (17.3%)
Travel$154.98 (1.1%)
Food & Beverage$21.73 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,554 | 32 | 81.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,450 | 3 | 17.3% |
| Travel and Lodging | $154.98 | 3 | 1.1% |
| Food and Beverage | $21.73 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14,159 | 38 | $0 (2024) |
| Olympus America Inc. | $21.73 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,605 | 6 | Novartis Pharmaceuticals Corporation ($2,605) |
| 2022 | $6,034 | 14 | Novartis Pharmaceuticals Corporation ($6,034) |
| 2021 | $2,560 | 8 | Novartis Pharmaceuticals Corporation ($2,560) |
| 2020 | $2,960 | 10 | Novartis Pharmaceuticals Corporation ($2,960) |
| 2018 | $21.73 | 1 | Olympus America Inc. ($21.73) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Neurology | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $77.79 | General |
| Category: Neurology | ||||||
| 02/20/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Neurology | ||||||
| 02/20/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $12.06 | General |
| Category: Neurology | ||||||
| 01/05/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Neurology | ||||||
| 01/05/2024 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Travel and Lodging | In-kind items and services | $65.13 | General |
| Category: Neurology | ||||||
| 11/21/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $37.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $83.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $107.27 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2022 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2022 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $93.08 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $54.99 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2022 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2022 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $113.13 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $45.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2021 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2021 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2021 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 673 | 3,480 | $1.7M | $727,742 |
| 2020 | 2 | 24 | 163 | $13,712 | $9,570 |
Total Patients
697
Total Services
3,643
Medicare Billing
$737,312
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 97610 | Therapy procedure using ultrasound | Office | 2023 | 119 | 1,020 | $1.1M | $418,738 | 39.1% |
| 11043 | Removal of muscle and/or tissue, 20.0 sq cm or less | Office | 2023 | 202 | 1,023 | $358,050 | $199,899 | 55.8% |
| 11046 | Removal of muscle and/or tissue, each additional 20.0 sq cm or less | Office | 2023 | 86 | 779 | $116,850 | $48,135 | 41.2% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 105 | 353 | $58,900 | $30,978 | 52.6% |
| 49450 | Replacement of stomach or large bowel tube using fluoroscopic guidance with contrast | Office | 2023 | 25 | 30 | $30,000 | $15,716 | 52.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 54 | 134 | $20,100 | $8,426 | 41.9% |
| 99342 | Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 30 | 30 | $7,400 | $1,875 | 25.3% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2023 | 27 | 44 | $6,600 | $1,785 | 27.0% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Office | 2023 | 14 | 56 | $5,600 | $1,778 | 31.7% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 11 | 11 | $1,100 | $412.06 | 37.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 11 | 88 | $9,684 | $7,014 | 72.4% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2020 | 13 | 75 | $4,028 | $2,556 | 63.4% |
About Dr. Curtis Cox, MD
Dr. Curtis Cox, MD is a Neurological Surgery healthcare provider based in Laguna Niguel, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760460588.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Curtis Cox, MD has received a total of $14,181 in payments from pharmaceutical and medical device companies, with $2,605 received in 2024. These payments were reported across 39 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($11,554).
As a Medicare-enrolled provider, Cox has provided services to 697 Medicare beneficiaries, totaling 3,643 services with total Medicare billing of $737,312. Data is available for 2 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurological Surgery
- Other Specialties Surgery
- Location Laguna Niguel, CA
- Active Since 01/03/2006
- Last Updated 09/27/2023
- Taxonomy Code 207T00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760460588
Products in Payments
- MAYZENT (Drug) $7,861
- GILENYA (Drug) $6,298
- ThunderBeat (Device) $21.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.